Animal IVD Market Report: Trends, Forecast and Competitive Analysis to 2035

Animal IVD Market

The future of the global animal ivd market looks promising with opportunities in the pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, and animal & plant quarantine department markets. The global animal ivd market is expected to reach an estimated $10.1 billion by 2035 from $5.4 billion in 2027 with a CAGR of 7.8% from 2027 to 2035. The major drivers for this market are the increasing demand for animal health diagnostics, the rising prevalence of zoonotic & infectious diseases, and the growing adoption of point of care testing.

• Lucintel forecasts that, within the type category, immunodiagnosis is expected to witness higher growth over the forecast period due to because of the high accuracy and reliability in detecting animal diseases.
• Within the application category, animal husbandry & veterinary system is expected to witness the highest growth over the forecast period due to because of the increasing need for livestock disease monitoring and preventive healthcare.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to because of the increase in the livestock population in the region.

Emerging Trends in Animal IVD Market

The animal ivd market is changing from centralized, episodic testing towards quick, decentralized diagnostics across veterinary clinics, farms, and research facilities. Over the next 3 years, the market will see an increased demand due to companion animal healthcare, disease surveillance, antimicrobial stewardship, as well as vertical access to molecular diagnostics. Lucintel's market viewpoint also projects technology integration as a principal driver of growth.

• Point-of-care Decentralization: In 2025, veterinary networks continued to install compact hematology, chemistry, immunoassay, and molecular systems that provide test results in a single consultation; systems that reduce analysis times from hours to minutes will have an advantage. This will result in an increased volume of testing, making diagnostics practical for rural veterinary clinics and livestock practices.
• Molecular Surveillance: During 2025-2027, laboratories will enhance their capacity for PCR, sequencing of antimicrobial resistance and emerging pathogens, as well as avian influenza; the World Organisation for Animal Health has identified more than 120 priority diseases for international reporting. The need for molecular tests for surveillance will drive market demand.
• Automation and Connectivity: In 2025, integrated analyzers more frequently linked test results to practice-management software, cloud-based dashboards, and automated quality controls; connected workflows reduced manual data entry and facilitated remote test result interpretation. In the next 3 to 5 years, interoperability will be the competitive differentiator for systems over standalone and current practice instruments.
• Preventive Animal Health: Veterinary care practitioners have a tendency to push wellness checks and screening to the forefront of care. This includes diabetes, kidney, and infectious disease screenings. According to the American Pet Products Association, the total expenditure on veterinary care in the United States in 2024 was $152 billion. The demand for veterinary lab reagents that will be needed for preventive testing should sustain and continue well beyond an episode of clinical care.
• Multiplex and Syndromic Testing: The ability to simultaneously detect and differentiate several pathogens or biomarkers with a single diagnostic test is a huge area of growth for both veterinary and human diagnostics. Improving diagnostic panels to incorporate multiple pathogen detection will facilitate better clinical decisions for diseases with similar or overlapping symptomatology. With the validation of these multiplex diagnostic tests, repeat sampling should be significantly reduced, and the diagnostic approach should improve, especially for farm animals and shelter and clinic based animals.

Supplier consolidation will likely continue to strengthen market segments. Growth will likely not stem from the sale of individual diagnostic devices. Instead, a greater focus on preventive veterinary care will likely affect the quality of revenue. Concurrent with regulatory policies and reimbursement, especially in the developing world, the clinical value of a diagnostic device will ultimately secure its market adoption.

Recent Developments in the Animal IVD Market

The animal ivd market is shifting away from central laboratories to connected, near-patient diagnostics. During this period of 2025-2027, Lucintel expects the market to remain steady due to the expansion of veterinary networks, automation of veterinary laboratories, and pet owners being more willing to spend on diagnostics. Lucintel has identified constant demand due to pet/livestock care, surveillance of livestock, antimicrobial stewardship, and the need for faster clinical decisions in various fragmented practice settings.

• Point-of-Care- Expansion: In 2024, revenue for IDEXX was reported to be $3.93 billion (February 2025). This continued the trend of pet clinics purchasing in-clinic analyzers and the accompanying reagents. During the next five years, there will be more opportunity for both market access and testing as well as strengthening client relationships.
• AI-Enabled Imaging: AI-based veterinary diagnostics were expanded by Mars Petcare through the digital pathology and imaging division of Antech, (January 2025). This will lead to an increase in the automation of diagnostics, eliminate the bottleneck created by the operative diagnostician, and improve the bottom line through software and diagnostics.
• Reference Laboratory Consolidation: IDEXX projected a total of $400 million for 2025 in laboratory system expansions and workflow automations (February 2025), consolidating the supply of reference laboratory services for both small and large veterinary practices. This will create better service for complex diagnostic cases.
• Livestock Surveillance: The European Commission allocated €165 million for veterinary programs in 2025 (January 2025) for disease monitoring and elimination. Public funding of veterinary diagnostics will drive the demand for molecular assays and Serology as well as the rapid tests in clinics for pet care and surveillance.
• Multiplex Molecular Testing: QIAGEN predicted 2024 revenue of $2.05 billion (February 2025), with syndromic and molecular diagnostics being a key area for growth. Veterinary clinics will adopt multiplex panels due to their differential diagnostics and outbreak control.

The volume of sales of assays will become less important compared to systems installed, installed assays, data services, and laboratory contracts. The market will be consolidated, however, with uneven clinic economics and regulatory pressures, this will separate small market players from the larger more efficient players. Offering diagnostics that are simple to perform integrated with flexible diagnostics will allow for market leaders to retain their position through 2027.

Strategic Growth Opportunities in the Animal IVD Market

The animal ivd market is expanding as the demand is arising for preventive care, livestock traceability and companion-animal insurance between 2024 and 2026. The labor shortage of veterinarians is also fueling demand for automated testing and decentralized diagnostics. Lucintel's market perspective also points to demand for differentiated platforms as clinics consolidate and manufacturers seek recurring consumables revenue.

• Point-of-care Automation: Compact analyzers allow clinics to perform routine chemistry and hematology faster and more efficiently than central laboratories. IDEXX reported 2024 revenue of $3.9 billion in February 2025, which demonstrates the potential of recurring demand for veterinary diagnostics. Over the next several years, automation of workflow will support even more testing performed by each veterinarian, and strengthened placement of diagnostic instruments.
• Molecular Infectious-disease Testing: Multiplex PCR and other isothermal assays offer faster identification of vector-borne pathogens. In January 2025, the USDA reported more than 136 million poultry were affected by Highly Pathogenic Avian Influenza since 2022. Disease outbreaks will increase demand for rapid diagnostics at farms, pet shelters, and specialty hospitals."
• Livestock Precision Diagnostics: Farmers are starting to move away from population-level treatments to more targeted diagnostics linked to both antimicrobial stewardship and productivity. The EU's Animal Health Law continues to be implemented in 2025 across member states and reinforces the obligation for traceability. Over the next 3 to 5 years, animal IVD suppliers will have the opportunity to sell testing services to dairy, swine, aquaculture, and poultry integrators.
• Premium Companion-animal Testing: There is growing demand for diagnostics for oncology, endocrine, cardiac and even genetic diseases because of growing owner expenditures and aging pets. Zoetis reported a $9.3 billion revenue figure for 2024 in February 2025, illustrating how the veterinary healthcare industry still has growing demand. Premium diagnostics will increase average revenue per patient because of rapidly increasing insurance and referral medicine.
• Digital Diagnostic Services: Cloud-connected diagnostics offer data for multi-site veterinary methods. In March 2025, Mars Veterinary Health acquired over 3,000 veterinary clinics globally. Continued consolidation will increase the value of subscription analytics and quality assurance services for animal IVDs.

Suppliers who successfully integrate diagnostics with service contracts and software will have a strong market position. Regulation will increase the cost of diagnostics for vendors, but accurate diagnostics for various species and samples will become increasingly valuable.

Animal IVD Market Drivers and Challenges

Animal IVD market growth is shaped by technological, economic, and regulatory factors. Demand for faster animal disease diagnoses grows with increasing livestock productivity, pet ownership, and preventive care. Digital, molecular, automation, and portable technologies are improving the access and accuracy of diagnostics. Regulatory constraints, sustainability, the veterinary supply chain, and the veterinary workforce influence diagnostic adoption. Lucintel believes competitive differentiation also involves turnaround time, affordability, test breadth, and clinical software integration for veterinary hospitals, laboratories, farms, and research.

The factors responsible for driving this market include:

• Growing Companion-Animal Healthcare Demand: Increased spending on pets and the perceived need for preventative care is driving the demand for blood chemistry, hematology, pathogen, and genetic tests. The American Pet Products Association estimates that the pet industry in the USA will grow to $150.6 billion by 2024. Continued investment in diagnostics is expected for the next five years due to aging pets, chronic health conditions, and the expected growth of pet insurance. This will especially impact veterinary hospitals in urban areas.
• Increasing Demand for Rapid Livestock Disease Diagnostics: Demand for rapid diagnostic tools is driven by increasing intensive agriculture, international movement of animals, and the economic impact of disease outbreaks on livestock (poultry, swine, cattle, and aquaculture) and their products. The World Organization for Animal Health reported more than 14,000 animal disease outbreaks in 2023, indicating the need for continuous disease surveillance and making the same need relevant in 2025. It is expected that in the next three to five years, producers and governments will prefer diagnostics that can provide rapid results to inform decisions on quarantine and minimize losses and support compliance with food safety regulations.
• Frontiers in Molecular Diagnostics and Digital Platforms: Sensitivity and time to result are improved by the combination of PCR and isothermal amplification, multiplexed panels, and a variety of biosensor technologies, while artificial intelligence and cloud computing provide real-time reporting and reduce the time to result. In January 2025, many veterinary diagnostic platforms shifted toward multiplexed diagnostic capability. This trend is expected to dominate the market in the next three to five years, as clinics and farms require rapid results in less than one hour, and digital technology facilitates results interpretation and reporting.
• Expanding The Frontiers of Point of Care and Mobile Veterinary Services: Lateral-flow, immunoassay, and molecular diagnostic systems designed to be used outside central laboratories are being developed and deployed to be used in remote clinics, animal shelters, veterinary outreach services, and laboratories. In 2025, point-of-care diagnostics had results available in 15 to 30 minutes, while laboratory diagnostics could take hours to complete. In the next three to five years, increased portability and digital connectivity will expand the deployment of diagnostics to remote and emergency situations, making rapid and frequent diagnostics easier to perform in resource limited regions.
• Automation and Manufacturing Advancements: Innovations in manufacturing technology and the improvement and standardization of reagents has allowed for automated sample preparation. Advancements in cartridges and consumables along with the manufacturing scale and efficiency has improved accuracy and consistency with a reduction in the workforce. By 2025, most labs used machines that could process dozens of samples in a single run, and even smaller clinics benefited from the advancement of the cartridge system. This trend is expected to drive the market growth in the next three to five years. This is primarily based on the reduction in labor costs per test, minimization of human error, and improved throughput and economy of advanced diagnostics for veterinary clinics and regional labs.

The challenges facing this market include:

• High Costs for Equipment and Tests: The costs associated with advanced equipment, proprietary consumables, controls and quality assurance materials, and labor and services contracts are extend beyond the reach of smaller practices and livestock operations. In 2025, the adoption of one molecular diagnostics system could cost thousands of dollars, creating substantial barriers in price sensitive areas for most veterinarian labs and clinics. In the next three to five years, low reimbursement rates, low and unpredictable income in veterinary services, will slow the adoption of diagnostics unless companies leased equipment, offered multiple pricing tiers, shared labs to reduce costs, and improved testing flexibility.
• Complex Regulations and Validations: Testing for veterinary diagnostics must account for variability in different species, different pathogens, different performance, different validation requirements, biosafety, labeling, and various national and regional requirements. In 2025, manufacturers and laboratories experienced different global approval and quality system standards that resulted in increased costs and length of time for validating different systems used in different regions. The lack of common systems will affect the veterinary diagnostics market for the next three to five years, but making harmonized systems with clearer requirements will encourage small companies to innovate since it will reduce the length of time needed to develop and validate products.
• Lack of Infrastructure and Staff: These regions may lack necessary infrastructure such as reliable electricity, cold-chain capacity, Internet, and veterinary technologists. In 2025, many field-testing programs were reliant on extended collection and referral laboratory procedures, which prolonged the time to result beyond the standard 24 hour turn-around time. It is projected that in the coming 3-5 years the overall quality of results will suffer as the field of infrastructure gaps continues to grow. The successful supplier of such systems will need to provide rugged devices, simplified workflow, remote support and training, and logistics for decentralized use.

The overall growth of the market is largely projected based on increasing owner care of companion animals, improving surveillance of livestock, progressive advances in the area of molecular biology and innovation, and the increased availability of point-of-care and automation technologies. However, there are a number of factors- high cost, complex regulations, and inadequate infrastructures - that will slow growth, particularly in smaller clinics and in developing regions. Competitors will succeed in this market if they can develop affordable units and supply chains, provide validated assays, easy to use software, and improved training. Over the coming 3-5 years, the overall market will be more connected, rapid, and prevention oriented, and the level of advanced diagnostic services available will be based on collaborative efforts of manufacturers, laboratories, veterinarians, and producers.

List of Animal IVD Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies animal ivd market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the animal ivd market companies profiled in this report include-

• Heska
• Zoetis
• Antech
• Eurofins Ingenasa
• IDEXX
• Bio-Rad
• Thermo Fisher Scientific
• Randox
• Idvet
• Edan Instruments

Animal IVD Market by Segment

The study includes a forecast for the global animal ivd market by type, application, and region.

Animal IVD Market by Type [Value ($B) from 2019 to 2035]:

• Immunodiagnosis
• Clinical Biochemistry & Molecular Diagnosis
• Hematology
• Others

Animal IVD Market by Application [Value ($B) from 2019 to 2035]:

• Pet Hospital
• Animal Husbandry & Veterinary System
• Zoo
• Research Institute Animal Experiment Center
• Animal & Plant Quarantine Department
• Others

Animal IVD Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Animal IVD Market

Activity in animal IVD markets is currently driven by public health surveillance, companion animal testing, and manufacturing that is concentrated within a region. Investments in regulations related to zoonotic disease preparedness, as well as company-driven automation, will drive procurement interests between 2025 and 2027. Lucintel's most recent report indicates that these trends should be closely monitored within the major national markets.

• United States: Surveillance and platform expansion by the government is the biggest driver. The USDA APHIS dedicated $1.5 billion to the H5N1 response in 2024, while Zoetis and IDEXX continued to expand their AI-enabled veterinary testing and the Vetscan Imagyst cloud-based offering, respectively (2025). These activities will influence the market by triggering the adoption of digital workflows and consumables that require frequent replacements within the next three to five years.
• China: Domestic veterinary diagnostics are strengthening and are in line with the government's disease-control programs. The Ministry of Agriculture and Rural Affairs required continued animal disease surveillance, while Mindray's veterinary offering focused on chemistry, hematology, and immunoassays (2025). In the coming years, these offerings will likely favor domestic integrated platforms and reduce reliance on imported equipment.
• Germany: European automation of laboratory testing and veterinary testing has been funded by German manufacturers. In fiscal 2025, Siemens Healthineers had projected €21.7 billion. German laboratories have begun fulfilling the requirements of the EU for animal health surveillance (November 2025). The country exerts its influence with high quality reference testing and the exportation of advanced lab technologies to the rest of Europe.
• India: The Public Veterinary Infrastructure and local production are both expanding. In the budget for 2025-26, the Indian Government had allocated ₹2,000 crore to the National Livestock Mission, along with the ICAR disease diagnostic programs (February 2025). This will enhance testing capacity and demand beyond city-based clinics, along with locally produced low-cost assays.
• Japan: The digitization and automation of veterinary diagnostics are ongoing. Fujifilm veterinary systems and DRI-CHEM animal health division have been actively deploying their systems while Japan's FY2025 animal disease control program continued to prioritize lab confirmation (April 2025). This will continue the demand for small reliable analyzers, reagents and digital traceable results.

Features of the Global Animal IVD Market

• Market Size Estimates: animal ivd market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: animal ivd market size by type, application, and region in terms of value ($B).
• Regional Analysis: animal ivd market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the animal ivd market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the animal ivd market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the animal ivd market by type (immunodiagnosis, clinical biochemistry & molecular diagnosis, hematology, and others), application (pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, animal & plant quarantine department, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?